Innate Pharma Financial Report: Highlights of GAAP EPS and Revenue Growth
Thursday, 21 March 2024, 09:21
Innate Pharma Financial Report
Innate Pharma has announced its financial results for FY 2023, revealing insights into their performance. The company reported a GAAP EPS of -€0.09 and revenue of €61.64M, indicating a 6.9% year-over-year increase.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.